Advertisement

Topics

The Lustgarten Foundation for Pancreatic Cancer Research Company Profile

11:37 EST 22nd November 2017 | BioPortfolio

Founded in 1998 by Cablevision executive Marc Lustgarten, with Cablevision chairman Charles Dolan and CEO James Dolan, The Lustgarten Foundation is the nation's largest private, non-profit supporter of pancreatic cancer research, providing more than $20 million to date. The Foundation provides patient information and manages a national public awareness campaign. To learn more and to see Dr. Pausch's PSA, visit www.lustgarten.org.


News Articles [4438 Associated News Articles listed on BioPortfolio]

Stand Up To Cancer, Lustgarten Foundation Award $2M to Pancreatic Cancer Research Team

Stand Up To Cancer has partnered with the Lustgarten Foundation for Pancreatic Cancer Research to sponsor a translational research team focused on applying chimeric antigen receptor T cell (CAR-T) the...

The Lustgarten Foundation for Pancreatic Cancer Research Release: Mechanism Of Metastasis Is Discovered In Pancreatic Cancer

  Life Sciences Jobs   ...

New Study Shows Promising Results In The Development Of More Effective Blood Test To Detect Pancreatic Cancer

WOODBURY, N.Y., Sept. 5, 2017 /PRNewswire-USNewswire/ -- A study published the week of September 4th in Proceedings of the National Academy of Science shows how combining mutations in circulating...

New SU2C-Lustgarten Foundation team aims to apply CAR T-cell therapy to pancreatic cancer

(American Association for Cancer Research) Stand Up To Cancer is supporting a new translational research team to explore how a type of immunotherapy that has been very successful in blood cancers can ...

SU2C launches 'cancer interception' initiative to detect & treat cancer at earliest stages

(Entertainment Industry Foundation) Stand Up To Cancer (SU2C), the Lustgarten Foundation for Pancreatic Cancer Research, LUNGevity, and the American Lung Association, have awarded a total of $16.6 mil...

Lustgarten Foundation Release: New Study Shows Promising Results In The Development Of More Effective Blood Test To Detect Pancreatic Cancer

  Life Sciences Jobs   ...

Sabga Foundation pledges $1 million towards TGen pancreatic cancer research

(The Translational Genomics Research Institute) Today, World Pancreatic Cancer Day, is the kickoff of a $1 million drive by the recently formed John E. Sabga Foundation to fund an innovative clinical ...

New research to combat pancreatic cancer

New research is underway that could help scientists combat the most lethal of cancers: pancreatic cancer. In a recent study, scientists demonstrated that bacteria in pancreatic tumors degrade a chemot...

PubMed Articles [8722 Associated PubMed Articles listed on BioPortfolio]

New Developments in the Molecular Mechanisms of Pancreatic Tumorigenesis.

Pancreatic cancer is an aggressive disease with a dismal prognosis in dire need of novel diagnostic and therapeutic approaches. The past decade has witnessed an explosion of data on the genetic altera...

KIF15 promotes pancreatic cancer proliferation via the MEK-ERK signalling pathway.

Pancreatic cancer is highly malignant and characterised by rapid and uncontrolled growth. While some of the important regulatory networks involved in pancreatic cancer have been determined, the cancer...

Accelerating Progress in the Fight Against Pancreatic Cancer Proceedings of the 2017 Leo and Anne Albert Symposium for Pancreatic Cancer Research.

TOP2A induces malignant character of pancreatic cancer through activating β-catenin signaling pathway.

It has been reported that Topoisomerase II alpha (TOP2A) could induce tumor development and progression in many cancer types. Herein, through analysis of different independent cohorts, we found TOP2A ...

Stereotactic body radiotherapy for unresected pancreatic cancer: A nationwide review.

The role of conventional radiotherapy in the management of pancreatic cancer has yet to be elucidated. Over the past decade, stereotactic body radiotherapy (SBRT) has emerged as a novel therapeutic op...

Clinical Trials [9593 Associated Clinical Trials listed on BioPortfolio]

EVIS - Ex-vivo Assessment of T-lymphocyte Homing in Primary Pancreatic Cancer

This is a single-centre, prospective, non-randomised research study. The research team will investigate the feasibility of assessing primary human pancreatic tissue for changes to T lympho...

Pancreatic Cancer Registry: For Any Person With a Personal or Family History

The NFPTR was established in 1994 to find the causes of pancreatic cancer. In brief, the investigators are interested in both the genetic and non-genetic causes of pancreatic cancer. The i...

Temsirolimus in Combination With Gemcitabine in Previously Untreated Metastatic Pancreatic Cancer

The purpose of this research study is to try to define the highest doses of temsirolimus and gemcitabine that can be used safely in combination to treat advanced pancreatic cancer. Gemcita...

K-001 Treatment of Advanced Pancreatic Cancer: Clinical Trial of Monotherapy's Tolerability

This study is an open and single-center Phase I clinical research on patients with advanced pancreatic cancer, for evaluating their adverse reactions or tolerance to K-001, so as to determ...

A Pilot Study of Diffusion MRI in the Assessment of Pancreatic Tumor Response

Patients with pancreatic cancer are treated with combinations of surgery, radiation therapy and chemotherapy, depending on the location of the cancer and other individual patient health fa...

Companies [3862 Associated Companies listed on BioPortfolio]

The Lustgarten Foundation for Pancreatic Cancer Research

Founded in 1998 by Cablevision executive Marc Lustgarten, with Cablevision chairman Charles Dolan and CEO James Dolan, The Lustgarten Foundation is the nation's largest private, non-profit support...

The Lustgarten Foundation

The Lustgarten Foundation, based in Bethpage, New York, is America's largest private foundation dedicated solely to funding pancreatic cancer research. Founded in 1998, the Foundation provides critica...

Sky Foundation, Inc.

After being diagnosed with pancreatic cancer in 2007 and responding well to treatment, Kasselman established Sky Foundation to fund research for the Sky Foundation Pancreatic Cancer Research Fund at t...

World Pancreatic Cancer Coalition

The World Pancreatic Cancer Coalition is an international group of pancreatic cancer patient advocacy groups with a mission to drive transformational change for all those affected...

Pancreatic Cancer Action Network

The Pancreatic Cancer Action Network is the only national organization creating hope in a comprehensive way through research, patient support, community outreach and advocacy for a cure. The organizat...

More Information about "The Lustgarten Foundation for Pancreatic Cancer Research" on BioPortfolio

We have published hundreds of The Lustgarten Foundation for Pancreatic Cancer Research news stories on BioPortfolio along with dozens of The Lustgarten Foundation for Pancreatic Cancer Research Clinical Trials and PubMed Articles about The Lustgarten Foundation for Pancreatic Cancer Research for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of The Lustgarten Foundation for Pancreatic Cancer Research Companies in our database. You can also find out about relevant The Lustgarten Foundation for Pancreatic Cancer Research Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Pancreatitis
Pancreatitis Acute pancreatitis is inflammation of the pancreas caused by the release of activated pancreatic enzymes. Common triggers are biliary tract disease and chronic heavy alcohol intake.  Diagnosis is based on clinical presentation...

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...


Corporate Database Quicklinks



Searches Linking to this Company Record